DAXX and neoplasm: Some studies have reported that DAXX/ATRX mutation is correlated with tumor stage and metastasis, and is associated with aggressive clinical behavior, reduced recurrence free survival (RFS) time, and worsening of the tumor-associated survival period [4,97,98,99].